Somaxon Pharmaceuticals to Present at Upcoming Fortis, Morgan Stanley

Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web site at www.somaxon.com. Contact Information: Somaxon Pharmaceuticals, Inc. Meg